SET Nuclear Oncogene (SET) (N-Term) Peptide
Quick Overview for SET Nuclear Oncogene (SET) (N-Term) Peptide (ABIN983601)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SET antibody (Catalog #: ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Background
-
SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alias Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
Protein Interaction Partner: ANP32A,APEX1,CDK5,CDK5R1,CDKN1A,ELAVL1,EP300,GZMA,HIST2H4A,HIST3H3,HMGB2,KLF5,MLL,NME1,PPP2CA,PPP2R1B,PTMA,RAC1,SET,SETBP1,SGOL1,TAF1A,THAP7,ANP32A,APEX1,CDK5R1,CDKN1A,DGKE,GZMA,HIST3H3,HIST4H4,HMGB2,KLF5,MEPCE,NME1,OTUD5,RGS20,SETBP1,TAF1A,THAP7,USP17L2,USP46,WDR48
Protein Size: 277 -
Molecular Weight
- 32 kDa
-
Gene ID
- 6418
-
NCBI Accession
- NM_003011, NP_003002
-
UniProt
- B2RCX0
Target
-